Cocrystal Pharma Inc. (COCP)

Cocrystal Updates Studies On Influenza and Bird Flu


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
June 21, 2024
Report ID: 26817
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$2.37 1.28%
Market Cap
$24.1M
Price Target
Refer to Report
Volume
13.7K
52wk Range
$1.325 - $3.285
Related Research Reports
7/19/2024

CDI-988 Reaches Milestone In Phase 1 Trial For Norovirus and Coronavirus
CDI-988 Reaches Milestone In Phase 1 Trial For Norovirus and Coronavirus (COCP)
6/21/2024

Cocrystal Updates Studies On Influenza and Bird Flu
Cocrystal Updates Studies On Influenza and Bird Flu (COCP)
5/14/2024

1Q24 Reported With Clinical Data Milestones On Schedule
1Q24 Reported With Clinical Data Milestones On Schedule (COCP)
11/14/2023

3Q23 Reported As Three Trials Make Progress
3Q23 Reported As Three Trials Make Progress (COCP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy